Option Care Health (NASDAQ:OPCH) Releases Q4 2024 Earnings Guidance

Option Care Health (NASDAQ:OPCH) updated its fourth quarter 2024 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 0.420-0.450 for the period, compared to the consensus estimate of 0.330. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.3 billion. Option Care Health also updated its FY 2024 guidance to 1.550-1.590 EPS.

Analyst Ratings Changes

A number of brokerages have recently weighed in on OPCH. JMP Securities restated a “market outperform” rating and set a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a research note on Friday. Barrington Research dropped their price target on Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research note on Thursday, October 31st. UBS Group started coverage on Option Care Health in a research note on Thursday, December 5th. They set a “neutral” rating and a $26.00 price target on the stock. Truist Financial dropped their target price on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. Finally, The Goldman Sachs Group lowered Option Care Health from a “buy” rating to a “neutral” rating and dropped their target price for the company from $38.00 to $27.00 in a research report on Monday, November 4th. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $29.14.

Option Care Health Stock Performance

NASDAQ OPCH traded up $2.36 during trading hours on Monday, reaching $26.35. The stock had a trading volume of 605,179 shares, compared to its average volume of 1,321,693. The stock has a fifty day moving average of $23.10 and a 200 day moving average of $27.69. The stock has a market cap of $4.48 billion, a P/E ratio of 22.14, a price-to-earnings-growth ratio of 2.43 and a beta of 1.31. Option Care Health has a 52-week low of $21.39 and a 52-week high of $34.63. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73.

Insider Buying and Selling at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the firm’s stock in a transaction on Friday, November 8th. The stock was bought at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the acquisition, the director now owns 326,334 shares of the company’s stock, valued at $7,355,568.36. The trade was a 15.18 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.64% of the stock is currently owned by corporate insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.